Clinical Trials Browser

Phase 2 × NSCLC × HM781-36B × Clear all

NCT03318939 2024-04-03

Phase 2 Study of Poziotinib in Participants With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation

Phase 2 Terminated

NSCLC

NCT04044170 2020-11-17

Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation

Phase 2 Terminated

NSCLC